MYO Stock Overview
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Myomo, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$3.27 |
52 Week High | US$5.58 |
52 Week Low | US$0.37 |
Beta | 1.51 |
1 Month Change | 6.51% |
3 Month Change | -34.73% |
1 Year Change | 336.00% |
3 Year Change | -75.26% |
5 Year Change | -90.76% |
Change since IPO | -98.53% |
Recent News & Updates
Shareholder Returns
MYO | US Medical Equipment | US Market | |
---|---|---|---|
7D | -9.4% | 2.3% | 0.2% |
1Y | 336.0% | 12.8% | 28.1% |
Return vs Industry: MYO exceeded the US Medical Equipment industry which returned 13.3% over the past year.
Return vs Market: MYO exceeded the US Market which returned 28.8% over the past year.
Price Volatility
MYO volatility | |
---|---|
MYO Average Weekly Movement | 15.5% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MYO's share price has been volatile over the past 3 months.
Volatility Over Time: MYO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 104 | Paul Gudonis | https://myomo.com |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, which includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprise of 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device.
Myomo, Inc. Fundamentals Summary
MYO fundamental statistics | |
---|---|
Market cap | US$99.71m |
Earnings (TTM) | -US$8.15m |
Revenue (TTM) | US$19.24m |
4.8x
P/S Ratio-11.4x
P/E RatioIs MYO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MYO income statement (TTM) | |
---|---|
Revenue | US$19.24m |
Cost of Revenue | US$6.06m |
Gross Profit | US$13.18m |
Other Expenses | US$21.33m |
Earnings | -US$8.15m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.29 |
Gross Margin | 68.51% |
Net Profit Margin | -42.34% |
Debt/Equity Ratio | 0% |
How did MYO perform over the long term?
See historical performance and comparison